Theralase Technologies Inc. announced that it will debut its next generation TLC-2000 Therapeutic Medical Laser System, at the Parker Seminar event in Las Vegas from January 14th to 16th, 2016. The TLC-2000 is a next generation therapeutic laser that has the ability to heal a patient's injury faster and more effectively than any other technology on the market. Chiropractors attending the meeting will be able to test-drive the system; including, it's ability to control 4 laser probes simultaneously to treat multiple locations on one or multiple patients, achieving higher efficiencies and better patient flow in their clinics.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.17 CAD | -2.86% |
|
-5.56% | -2.86% |
Jul. 08 | Theralase Technologies Inc. announced a financing transaction | CI |
Jun. 20 | Theralase Technologies Inc. Announces Rutherrin Repurposes Non-Cancer Drugs for Cancer Therapy | CI |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-2.86% | 31.04M | |
+2.67% | 852M | |
-34.22% | 197M | |
0.00% | 87.56M | |
-25.93% | 84.71M |
- Stock Market
- Equities
- TLT Stock
- News Theralase Technologies Inc.
- Theralase Technologies Debuts Next Generation Therapeutic Laser in US